Q3 2013

Filed Nov 14, 2013 · 10-Q · 45 days after period end · 0001354488-13-006341

Q3 2013 · 10-Q

Revenue

$472.75K

+31.2% vs Q3 2012

Net Income

-$1.69M

N/M vs Q3 2012

EPS Diluted

-$0.02

N/M vs Q3 2012

Gross Profit$234,016+55.2%

Operating Cash Flow

Same quarter

Metric	Q3 2013	Q3 2012	Q3 2011	Q3 2010
Revenue	$472.75K	$360.25K	$133.84K	$111.65K
Net Income	-$1.69M	-$1.40M	-$337.84K	-$1.69M
EPS Diluted	-$0.02	-$0.02	-$0.01	-$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR